Soo Jeong Nam

Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status

Jaemoon Koh, Heounjeong Go, Bhumsuk Keam et al. · Modern Pathology · 2015 · 159 citations · Full text

Medicine, Oncology, Pathology +17

Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas

Dohee Kwon, Sehui Kim, Pil‐Jong Kim et al. · Histopathology · 2015 · 153 citations

Life Sciences, Oncology, Pathology +17

An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone

Soo Jeong Nam, Heounjeong Go, Jin Ho Paik et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 121 citations

Life Sciences, Immunology, Oncology +16

MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma

Heounjeong Go, Ji-Young Jang, Pil-Jong Kim et al. · Oncotarget · 2015 · 116 citations · Full text

Medicine, Oncology, Pathology +17

Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis

Wook Youn Kim, Ho Young Jung, Soo Jeong Nam et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2016 · 82 citations

Life Sciences, Immunology, Oncology +14